Seizure threshold
harm-reductionThe level of neural excitability at which a person's brain produces a seizure, which some substances, some medications, and withdrawal states lower. It is a relative property rather than a fixed line: a threshold lowered enough to matter in someone with an existing seizure disorder may never be crossed in someone without one.
The seizure threshold is the level of neural excitability at which the brain generates a seizure — a sudden, abnormal discharge of electrical activity across a network of neurons. It is not a fixed physiological value: it varies between people, shifts with health and sleep state, and can be temporarily lowered by certain substances, medications, and withdrawal processes.
In the context of substance use, the concept matters because a meaningful number of compounds reduce seizure threshold — by suppressing inhibitory signalling, by driving neurochemical rebound during withdrawal, or by stacking effects when taken in combination. A person whose baseline risk is already elevated, due to a seizure disorder, a relevant medication, or recent CNS depressant use, occupies different risk territory than someone without those factors.
How it is done
Accounting for seizure threshold risk is not a single test but a set of checks identified before and during substance use. The starting point is recognising which risk factors apply: a personal or family history of seizures; a current diagnosis such as epilepsy; use of medications that affect seizure threshold, including some antidepressants, antipsychotics, and stimulant medications; and dependence on alcohol, benzodiazepines, or barbiturates — since abrupt withdrawal from CNS depressants carries its own, potentially severe, seizure risk.
Substances with a well-documented threshold-lowering effect include stimulants at elevated intake, tramadol (which has a more prominent pro-convulsant profile than most opioids), and some synthetic cannabinoids. The risk compounds when multiple factors are present simultaneously.
Practical responses include disclosing substance use to a prescribing physician so that medication interactions can be assessed; avoiding combinations known to compound this risk; and not stopping long-term CNS depressant use abruptly, since withdrawal seizures can be life-threatening and typically require medical supervision to manage safely.
When it matters
If a seizure occurs, it is a medical emergency regardless of suspected cause. The immediate priority is preventing injury: clearing hard or sharp objects from the area, not restraining the person, and placing them in the recovery position — on their side — once convulsions have passed, to reduce the risk of aspiration.
Emergency services should be contacted if the seizure extends beyond a few minutes, if a second seizure follows without a full recovery interval, or if the person does not regain consciousness in the expected window. Both stimulant toxicity and CNS depressant withdrawal can produce a first seizure with ongoing risk of further seizures; the physical event does not necessarily mark the end of the danger.
What it cannot tell you
Knowing that a substance lowers the seizure threshold does not establish whether any particular episode of use will trigger a seizure. The threshold is a statistical property, not a personal value that can be measured or tracked. Most people who use threshold-lowering substances do not seize — but that probability is not stable across time or circumstance.
A history of uneventful prior use should not be read as confirmation that the threshold is safe. Cumulative neurological load, changes in baseline health, sleep deprivation, new combinations, and escalating quantity can all shift the threshold without any preceding warning sign.
The concept also cannot substitute for clinical assessment. Only a neurologist or prescribing physician, with knowledge of a person's full medication list, history, and current health state, can estimate seizure risk with any precision. A reassuring absence of past seizures is relevant information, but it does not rule out future risk.
AI-generated · not yet verified by a human reviewer
Harm-reduction reference — not medical advice.